TRIUMVIRA IMMUNOLOGICS
Triumvira Immunologics, Inc. (“Triumvira”) is an immunotherapy company co-founded in 2015 by Dr. Jonathan Bramson at McMaster University and Bloom Burton & Co., with the vision of developing novel T cell therapies that are safer and more efficacious than current cancer treatments, including chimeric antigen receptor (CAR) and engineered T cell receptor (TCR) therapies. Their proprietary T cell Antigen Coupler (TAC) technology recruits the entire natural T cell receptor and is independent of the major histocompatibility complex (MHC), allowing for the development of better therapies for a broader range of patients with solid or liquid malignancies and also with diseases other than cancer.
TRIUMVIRA IMMUNOLOGICS
Social Links:
Industry:
Biotechnology Clinical Trials Health Care
Founded:
2015-01-01
Address:
Austin, Texas, United States
Country:
United States
Website Url:
http://www.triumvira.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
100 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Harpoon Therapeutics
Harpoon Therapeutics is a clinical-stage immunotherapy company developing novel T cell engagers (TriTACs) for the treatment of cancer.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
Vor Biopharma
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.
Current Advisors List
Current Employees Featured
Founder
Investors List
Myeloma Investment Fund
Myeloma Investment Fund investment in Series A - Triumvira Immunologics
Multiple Myeloma Research Foundation
Multiple Myeloma Research Foundation investment in Series A - Triumvira Immunologics
Northpond Ventures
Northpond Ventures investment in Series A - Triumvira Immunologics
Leaps by Bayer
Leaps by Bayer investment in Series A - Triumvira Immunologics
B Capital Group
B Capital Group investment in Series A - Triumvira Immunologics
ATEM Capital Fund LP
ATEM Capital Fund LP investment in Series A - Triumvira Immunologics
Northpond Ventures
Northpond Ventures investment in Series A - Triumvira Immunologics
Bloom Burton & Co.
Bloom Burton & Co. investment in Series A - Triumvira Immunologics
Centre for Commercialization of Cancer Immunotherapy
Centre for Commercialization of Cancer Immunotherapy investment in Series A - Triumvira Immunologics
Leaps by Bayer
Leaps by Bayer investment in Series A - Triumvira Immunologics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-10-28 | Triumvira Appoints Oncology Industry Veteran Deyaa Adib, M.D., as Chief Medical Officer |
Official Site Inspections
http://www.triumvira.com Semrush global rank: 4.68 M Semrush visits lastest month: 2.08 K
- Host name: 47.107.198.104.bc.googleusercontent.com
- IP address: 104.198.107.47
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
